Vernalis (R&D) Ltd.
Records under this name other than the patents Vernalis (R&D) Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 34 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,610,290 | Thienopyrimidine compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,920,066 | Thienopyrimidine compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,556,911 | Thienopyrimidine compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,028,097 | Thienopyrimidine compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,450,346 | Azetidine derivatives as FAAH inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,006,269 | Azetidine Derivatives Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,475,800 | Azetidine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,383,871 | Azetidine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,918,640 | Azetidine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,376,443 | Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record |